The Galleri test aims to find fragments of DNA in a person’s blood that can indicate the presence of a cancerous tumor.

Research published in the journal BMJ Open in May found that an annual blood test for cancer could lead to 49 per cent fewer ...

A seven-time Olympic medalist was diagnosed with ovarian cancer after missing the same three warning signs common in early ...

Without an easy way to screen and with nondescript symptoms, ovarian cancer is often caught in late stages, requiring massive ...

The new test, called the risk of ovarian cancer algorithm (Roca), calculates a woman’s individual risk based on factors such ...

Researchers are studying tests called liquid biopsies, which can provide vital information about cancer genes using only a blood sample. A blood test to find cancer even before it shows any symptoms ...

Ovarian cancer is an abnormal growth of cells or tumors in the ovaries. Some forms of ovarian cancer are more aggressive than ...

June 14, 2010 — The US Food and Drug Administration (FDA) has cleared a chemiluminescent microparticle immunoassay (Architect human epididymis protein 4 [HE4] assay; Abbott Diagnostics) for the ...

Jessica Gilbert's unexpected ovarian cancer diagnosis underscores the disease's subtle symptoms and the critical need for early detection. Often called a "silent killer," ovarian cancer lacks a ...

Even after Merck & Co.’s Keytruda has climbed to the top of the industry’s sales charts and racked up dozens of FDA-a | A Keytruda-based regimen has shown a statistically significant overall survival ...

Sept. 12 -- FRIDAY, Sept. 11 (HealthDay News) -- The U.S. Food and Drug Administration has approved a new test for women with pelvic tumors that are known to need surgery. The test, called OVA1, will ...